![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61P 43/00 | (2006.01) |
A61P 31/12 | (2006.01) | ||
A61P 31/18 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/02 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 3597216 |
(13) | Kind of document | T |
(96) | European patent application number | 19186310.9 |
Date of filing the European patent application | 2009-08-11 | |
(97) | Date of publication of the European application | 2020-01-22 |
(45) | Date of publication and mention of the grant of the patent | 2022-08-24 |
(46) | Date of publication of the claims translation | 2022-11-10 |
(30) | Number | Date | Country code |
188548 P | 2008-08-11 | US |
(72) |
THUDIUM, Kent B. , US
KORMAN, Alan J. , US
LEBLANC, Heidi , US
YAMANAKA, Mark , US
SELBY, Mark , US
ZENS, Kyra, D. , US
|
(73) |
E. R. Squibb & Sons, L.L.C. ,
Route 206 and Province Line Road, Princeton, NJ 08540,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Žmogaus antikūnai, kurie riša limfocito aktyvavimo geną-3 (LAG-3) ir jų naudojimas |
HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-07-03 | 17 | 347.00 EUR |
2026-08-11 |